FDAnews Drug Daily Bulletin

Sanofi Pulls Leukaemia Drug Ahead of Possible OK for Lemtrada

Aug. 21, 2012
A A
Sanofi's rare disease unit Genzyme is pulling leukaemia drug Campath to prepare for its launch under a different dosage and as a multiple sclerosis treatment that will be branded as Lemtrada.
Yahoo! Finance